Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Print this page Email this page Users Online: 181

 Table of Contents  
Year : 2015  |  Volume : 4  |  Issue : 2  |  Page : 134-135

Neoadjuvant chemotherapy in neonatal Wilms' tumor

Department of Pediatric Surgery, Niloufer Hospital, Hyderabad, India

Date of Web Publication12-Jun-2015

Correspondence Address:
Dr. Ramesh K Reddy
Plot no. 36, Snehapuri Colony, Nacharam, Hyderabad - 500 076
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2277-8632.158601

Rights and Permissions

Neonatal presentation of Wilms' tumor is rare with an incidence of 0.16%. The treatment protocol has to be tailored according to the need. Most studies recommend nephroureterectomy followed by chemotherapy. We present our experience with a baby who came with stage 2 Wilms' tumor in the neonatal period and was treated using neoadjuvant chemotherapy.

Keywords: Neonate, Wilms′ tumor, neoadjuvant chemotherapy

How to cite this article:
Reddy RK, Kannaiyan L, Srirampur S, Irfan GM, Rao S. Neoadjuvant chemotherapy in neonatal Wilms' tumor. J NTR Univ Health Sci 2015;4:134-5

How to cite this URL:
Reddy RK, Kannaiyan L, Srirampur S, Irfan GM, Rao S. Neoadjuvant chemotherapy in neonatal Wilms' tumor. J NTR Univ Health Sci [serial online] 2015 [cited 2022 Dec 3];4:134-5. Available from: https://www.jdrntruhs.org/text.asp?2015/4/2/134/158601

  Introduction Top

Wilms' tumor is the most common abdominal malignancy in infancy, after neuroblastoma. The treatment protocols are well established in national Wilms tumour study (NWTS) and International Society of Pediatric Oncology (SIOP) protocols. Neonatal presentation of Wilms' tumor is rare. The current NWTS and SIOP protocols suggest primary nephrouretectomy followed by chemotherapy with dose reduction. Our patient presented with a large Wilms' tumor which was treated by nephroureterectomy following reduction in size of the lesion, with neoadjuvant chemotherapy tailored for the case.

  Case Report Top

A 20-day-old baby was brought for a large abdominal mass. Upon investigation it was found to be a renal mass measuring 72 × 71 × 91 mm, crossing the midline. It was not invading the vessels. A trucut needle biopsy revealed a triphasic Wilms' tumor [Figure 1]. In view of the size of the mass and concerns regarding spillage during surgery, neoadjuvant chemotherapy was decided. Baby received 4 cycles of chemotherapy with Actinomycin-D and Vincristine at half the calculated dose. Chemotherapy was well tolerated and there was significant reduction in the size of the lesion. The child underwent nephroureterectomy. Postoperative chemotherapy was continued for 24 weeks [Figure 2]. Radiotherapy was not administered. At follow-up, after 1 year, the child was thriving well without any recurrence.
Figure 1: CT abdomen showing large left renal tumor with local infiltration

Click here to view
Figure 2: Resected specimen (following 4 cycles of chemotherapy)

Click here to view

  Discussion Top

Neonatal renal tumors constitute 7% of all neonatally detected tumors. [1] Congenital mesenchymal nephroblastoma is the most common of these tumors. Also, 15% [1] of the patients are diagnosed antenatally. Some are associated with  Beckwith-Wiedemann syndrome More Details or WAGR syndrome or Denys-Drash syndrome. [1],[2] It has been observed that even aggressive tumors in neonates have a better prognosis than a presentation at an older age. [2]

Ritchey et al. [2] studied the management of Wilms' tumors presenting in the neonatal period. They studied 15 newborns. All underwent nephroureterectomy. Ten received adjuvant chemotherapy with 50% dose reduction (as recommended by NWTS-3 protocol). Among the five babies who did not receive adjuvant chemotherapy or radiotherapy, one developed recurrence. NWTS-5 recommends primary nephroureterectomy followed by radiation and chemotherapy in all children. In infants less than 1 year of age, 50% dose reduction is recommended due to increased incidence of toxicity. [3],[4] Radiation is avoided due to long-term sequelae. [5] Stage I patients are treated with surgery alone. Stage II and above are treated with chemotherapy regimen depending on the extent of the lesion and loss of heterozygosity (LOH) at markers. Neoadjuvant chemotherapy is recommended in tumors associated with syndromes, unilateral kidney tumors, or bilateral tumors. [1] Patients with nephrogenic rests need close follow-up to detect metachronus tumors. [2] The event-free survival in neonatal Wilms' is 86% and overall survival is 93%. [1]

According to the SIOP protocol, Powis [1] recommended nephrectomy in patients of less than 6 months of age with unilateral renal tumors. In those patients with inoperable or bilateral tumors, neoadjuvant chemotherapy and partial nephrectomy are recommended. A 50% dose reduction of chemotherapy is recommended in infants less than 6 months of age.

In our patient, the tumor appeared to be non-resectable due to massive size crossing the midline. Neoadjuvant chemotherapy was given (DD-4A) for 4 cycles. There was a marked reduction in size of the tumor and nephroureterectomy was done. The child completed the remaining course of the chemotherapy. Patient was able to tolerate the chemotherapy without adverse effects.

In conclusion, neonatal Wilms' tumor can be successfully treated with a combination of surgery and neoadjuvant chemotherapy where indicated.

  References Top

Ritchey ML, Azizkhan RG, Beckwith JB, Hrabovsky EE, Haase GM. Neonatal Wilms' Tumour. J Pediatr Surg 1995;30:856-9.  Back to cited text no. 1
Morgan E, Baum E, Breslow N, Takashima J, D'Angio G. Chemotherapy-related toxicity in infants treated according to the Second National Wilms' Tumor Study. J Clin Oncol 1988;6:51-5.  Back to cited text no. 2
Corn BW, Goldwein JW, Evans I, D'Angio GJ. Outcomes in low-risk babies treated with half-dose chemotherapy according to the Third National Wilms' Tumor Study. J Clin Oncol 1992;10:1305-9.  Back to cited text no. 3
Evans AE, Norkool P, Evans I, Breslow N, D'Angio GJ. Late effects of treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. Cancer 1991;67:331-6.  Back to cited text no. 4
Powis M. Neonatal renal Tumours. Early Hum Dev 2010;86:607-12.  Back to cited text no. 5


  [Figure 1], [Figure 2]

This article has been cited by
1 Profile and Clinical Outcome of Children with Wilms' Tumor treated at a Tertiary Care Centre, India
Pritanjali Singh, Dharmendra Singh, Bindey Kumar, Prem Kumar, Punam Prasad Bhadani
South Asian Journal of Cancer. 2022;
[Pubmed] | [DOI]


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article
Case Report
Article Figures

 Article Access Statistics
    PDF Downloaded259    
    Comments [Add]    
    Cited by others 1    

Recommend this journal